Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Canopy Growth Corporation, through its subsidiaries, is a producer of medical marijuana. The Company`s group of brands represents distinct voices and market positions designed to appeal to an array of customers, doctors and strategic industry partners.
  • Current market environment: positive. Prices of production are 10.2% higher compared to the last 12 months (LTM)
  • Prices of production are at 43.4% percentile over the past 5 years, adjusted for inflation
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 28.4% (LTM), projected 31.2%
  • Share price is 266.4% higher than minimum and 90.8% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-5.2x vs
    )
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (
    vs
    )
  • For the last 3 months insiders sold company shares on $0.2 mln (-0.016% of cap.)

Key Financials (Download financials)

Ticker: CGC
Share price, USD:  (-1.4%)1.37
year average price 2.2454  


year start price 4.7900 2024-09-15

max close price 5.5900 2024-11-05

min close price 0.8282 2025-04-08

current price 1.3700 2025-09-14
Common stocks: 550 459 365

Dividend Yield:  0.0%
FCF Yield LTM / expected: 28.4% / 31.2%
EV / LTM EBITDA: -5.2x
Production prices change from LTM: 10.2%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 754
Net Debt ($m): 152
EV (Enterprise Value): 906
EBITDA LTM ($m): -174
EV / LTM EBITDA: -5.2x
Price to Book: 2.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2025-08-08zacks.com

Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates

2025-08-01zacks.com

Canopy Growth Corporation (CGC) Advances While Market Declines: Some Information for Investors

2025-07-25zacks.com

Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know

2025-07-25businesswire.com

Canopy Growth to Report First Quarter Fiscal 2026 Financial Results on August 8, 2025

2025-07-18zacks.com

Canopy Growth Corporation (CGC) Falls More Steeply Than Broader Market: What Investors Need to Know

2025-06-30newsfilecorp.com

Canadian Gold Corp. Closes Over-Subscribed Private Placement for New Hammond Reef South Program

2025-06-27zacks.com

Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors

2025-06-25marijuanastocks.com

Here Is A List Of 3 Canadian Marijuana Stocks To Watch 2025

2025-06-19newsfilecorp.com

Canadian Gold Corp. Private Placement Offering for New Hammond Reef South Program to Follow up 2024 Surface Samples That Returned 35.4 g/t Gold

2025-06-14fool.com

1 Beaten-Down Stock Down 99% That's Still Not Worth Buying
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company